Fondaparinux Sodium Injection, Solution
Product Images NDC 11797-154

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Fondaparinux Sodium (NDC 11797-154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Italfarmaco S.p.a, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5406

Folded carton labeling for Fondaparinux Sodium Injection USP, 2.5 mg/0.5 mL strength, intended for subcutaneous injection. The label indicates the product is a single dose, prefilled syringe with an automatic needle protection system. The carton includes manufacturer Italfarmaco S.p.A. and distributor Zydus Pharmaceuticals (USA) Inc. The label provides usage, storage information, and barcode details for a 10 x 0.5 mL package.*

FDA Label Image

5409

Packaging label for Fondaparinux Sodium Injection USP 2.5 mg / 0.5 mL in prefilled syringes. The box contains 2 single-dose prefilled syringes for subcutaneous use. Labeler is Italfarmaco S.p.A and distributor is Zydus Pharmaceuticals (USA) Inc. Storage and handling instructions and barcode are visible.*

FDA Label Image

5506

Packaging label for Fondaparinux Sodium Injection USP, 5 mg/0.4 mL, a subcutaneous injection solution. The box contains 10 single-dose prefilled syringes. Labeler information includes Italfarmaco S.p.A. and distribution by Zydus Pharmaceuticals (USA) Inc. The label also highlights the syringe's automatic needle protection system and provides storage instructions and contents details.*

FDA Label Image

5509

Box packaging label for Fondaparinux Sodium Injection USP 5 mg/0.4 mL, a subcutaneous injection sold in single-dose prefilled syringes. The package contains 2 syringes and includes labeling for pharmacist dispensing and storage information. Manufactured by Italfarmaco S.p.A. and distributed by Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

5606

Packaging label for Fondaparinux Sodium Injection USP, 7.5 mg/0.6 mL, a single dose prefilled syringe for subcutaneous injection. The label includes dosing information, storage instructions, and manufacturer details (Italfarmaco S.p.A.). Distributed by Zydus Pharmaceuticals (USA) Inc. The carton contains 10 prefilled syringes with automatic needle protection system.*

FDA Label Image

5609

Packaging label for Fondaparinux Sodium Injection USP 7.5 mg/0.6 mL, containing 2 single dose prefilled syringes for subcutaneous use. The label states the product is affixed with an automatic needle protection system and is manufactured by Italfarmaco S.p.A. and distributed by Zydus Pharmaceuticals (USA) Inc. Additional storage and contents information is included on the label.*

FDA Label Image

5706

Packaging label for Fondaparinux Sodium Injection USP, 10 mg / 0.8 mL, a single dose prefilled syringe for subcutaneous use. The label indicates automatic needle protection and is manufactured by Italfarmaco S.p.A and distributed by Zydus Pharmaceuticals (USA) Inc. The package contains 10 prefilled syringes.*

FDA Label Image

5709

Packaging label for Fondaparinux Sodium Injection USP, 10 mg/0.8 mL injection solution for subcutaneous use. The label indicates a package containing 2 single-dose prefilled syringes. It is manufactured by Italfarmaco S.p.A. and distributed by Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

12 (Figure12)

Two-panel instructional illustration showing proper use of fondaparinux sodium injection. Figure 1 depicts hands removing the cap from the prefilled syringe for subcutaneous injection. Figure 2 shows a healthcare professional administering the injection subcutaneously in the abdominal area using the syringe with fondaparinux sodium solution.*

FDA Label Image

34 (Figure34)

Two black and white instructional images depicting the subcutaneous administration of an injection into the abdominal area. A gloved hand is holding a syringe as it is inserted into the skin near the navel, demonstrating the technique for fondaparinux sodium injection, solution dosing.*

FDA Label Image

5 (Figure5)

An instructional illustration showing a hand holding a prefilled syringe, indicating a step in using the injection device with an arrow pointing to the syringe barrel. The syringe likely contains fondaparinux sodium injection solution for subcutaneous administration.*

FDA Label Image

Selfinj1 (Selfinj1)

Instructional diagram showing parts of the fondaparinux sodium injection safety syringe including rigid needle guard, plunger, finger-grip, and security sleeve. Images depict the syringe before and after use. Additional photos demonstrate sitting or lying position for self-injection on the lower abdomen area, with instructions for handwashing and cleaning the injection site with an alcohol swab.*

FDA Label Image

Selfinj2 (Selfinj2)

Instructional illustrations for subcutaneous injection technique of fondaparinux sodium. Figure B shows removal of the needle shield from the syringe, Figure C depicts gently pinching the skin to form a fold, and Figure D demonstrates inserting the needle at a 90° angle into the skin fold with the syringe held firmly.*

FDA Label Image

Selfinj3 (Selfinj3)

Illustrations showing how to inject fondaparinux sodium injection subcutaneously and activate its safety system. Figure E depicts pressing the plunger down to inject all medicine, and Figure F shows removing the syringe while activating the needle safety shield by pushing the plunger rod. Additional notes caution on proper safety system activation and handling after injection.*

FDA Label Image

Selfinj4 (Selfinj4)

Text panel titled "Disposing of used - fondaparinux sodium injection needles and syringes" providing instructions for safe disposal. It advises using an FDA-cleared sharps disposal container or a heavy-duty household container meeting specific criteria. Additional guidance includes following community disposal guidelines when the container is full and avoiding disposal in household trash unless permitted. Manufacturer and distributor information for Italfarmaco S.p.A. and Zydus Pharmaceuticals (USA) Inc. are also shown.*

FDA Label Image

Structure

Chemical structure of fondaparinux sodium, showing the molecular arrangement and functional groups of the active ingredient present in this human prescription injection solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.